MTHFR symptoms: what a gene result can tell you, and what it cannot
There is no such thing as an MTHFR symptom, and that is the most useful sentence I can give you. The things people call MTHFR symptoms, the tiredness, the fog, the flat mood, the broken sleep, are real. They just come from things that are far more common than a gene variant, and a great deal easier to check.
If you have ended up here, you have probably been tired for a while, and someone has probably told you your bloods are fine. I understand why one gene that touches folate, energy, mood and hormones starts to feel like the answer.
MTHFR is the most searched gene in my inbox, and it is almost never where I start. Not because it is nonsense. The gene is real, the enzyme is real, and folate genuinely matters. But somewhere between the biochemistry and the search results it turned into an explanation for everything, and that is where people lose a year.
The short version
- No symptom belongs to MTHFR. The ones people search, tiredness, brain fog, low mood and broken sleep, all have more common explanations that get checked first.
- Between 60 and 70 per cent of people carry at least one of the two common variants, and about one in ten carries two. It is not a rare finding.
- The RACGP tells GPs not to order this test, because the result does not change what happens next.
- In the biggest pooled trial data on the idea behind it, lowering homocysteine by a quarter in 37,485 people moved none of the outcomes counted.
- Your folate, B12 and homocysteine are blood tests. They move, and they are the part you can actually do something about.
Why one gene ends up explaining everything
Methylation is involved in a lot: how folate gets used, how homocysteine is processed, how some neurotransmitters are put together. So when you read that MTHFR affects methylation, and that methylation affects everything, the arithmetic feels like it works.
It does not, and the reason is small but load-bearing. A pathway being involved in something is not the same as a variation in that pathway being why yours is struggling.
The pathway is real. The jump from the pathway to your Tuesday is where it comes apart.
What MTHFR actually does
MTHFR is short for methylenetetrahydrofolate reductase. It makes an enzyme that converts one form of folate into the form that circulates in your blood, and that form is what turns homocysteine back into methionine.
Two variants get tested: 677C>T and 1298A>C. Your report will say heterozygous (one copy), homozygous (two copies of the same one) or compound heterozygous (one of each).
Now the number that reframes the whole conversation. In the general population, 60 to 70 per cent of people carry at least one of these two variants. About 8.5 per cent are homozygous for one of them and 2.25 per cent are compound heterozygous, so roughly one in ten people carries two copies.
If two thirds of a waiting room shares your finding, it is not the thing separating you from the person sitting next to you.
Worth knowing as well: in the homozygous or compound heterozygous form, these two variants reduce enzyme production only mildly. Severe MTHFR deficiency is a different, rare and serious inherited condition, and it is not caused by either of them.
There is no list of MTHFR symptoms
This is the part nobody wants to hear at 10pm.
The RACGP's own patient sheet on MTHFR says a variation can reduce the gene's effectiveness, but that this has “very little to no impact on people's health”, and that people with the same condition get the same care whether they carry a variation or not.
In 2013 the American College of Medical Genetics went further. MTHFR polymorphism testing has minimal clinical utility, they said, and should not be ordered as part of a routine thrombophilia work-up, because the associations behind the idea had not held up in the meta-analyses.
I am not quoting them to tell you your symptoms are imaginary. They are not. I am quoting them because the list you searched, tiredness, fog, flat mood, broken sleep, is the same list produced by low iron, thyroid changes, low B12, blood sugar swings, sleep apnoea and perimenopause. Every one of those is cheaper to check, and every one of them can change. It is the same argument I made about being tired when your bloods came back normal, and if mood and sleep are the loudest part of it for you, that is where we would usually start.
The largest test of the idea, and what it found
The logic behind MTHFR care runs like this. The variant slows the enzyme, the enzyme's job affects homocysteine, high homocysteine is bad for you, so bring the homocysteine down. Every link sounds reasonable on its own.
In 2010 a group at Oxford pooled the individual participant data from eight randomised placebo-controlled trials, 37,485 people at raised cardiovascular risk, and tested the last link directly. Folic acid lowered homocysteine by an average of 25%. Over a median of five years, this is what that did to the outcomes they counted.
Read the vertical line first. It is “no difference”. Every dot sits on or beside it, and every horizontal line through a dot, which is the range the trials could not rule out, crosses it.
The marker moved a quarter. Nothing else moved.
Two caveats, because they are real. These were people already at raised cardiovascular risk, not tired forty-somethings. And the trials counted heart attacks, strokes, cancers and deaths, not tiredness or brain fog, because nobody has run that trial. What it does tell you is that the hard outcome this pathway was supposed to predict did not budge when the marker did. If long-term markers are genuinely what you are chasing, that is a different conversation and a different set of tests.
What I would look at before the gene
When someone sends me a gene report and asks what to do with it, I ask what else has been checked. The answer is usually “my bloods were normal”, and when we read the actual results, two or three of the things below have never been on a form.
| If this sounds like you | Ask your GP about | Why it is on the list |
|---|---|---|
| Flat, breathless on stairs, heavy periods | Full blood count and iron studies, including ferritin | Low iron stores produce the fog and the fatigue long before anaemia shows up on a full blood count |
| Cold, slow, foggy, weight creeping on | TSH, with free T4 if TSH is out of range | An underactive thyroid looks almost exactly like the picture MTHFR gets blamed for |
| Pins and needles, poor recall, vegetarian or on long-term reflux medication | Vitamin B12 and folate | These are the two nutrients in this pathway, and unlike the gene they can be measured today |
| You have been told to bring your homocysteine down | Homocysteine, with B12 and folate on the same form | Homocysteine is the thing being worried about, and unlike the gene it can be measured and it can change |
| Snoring, waking unrefreshed, a partner who has noticed pauses | A referral for a sleep study | Sleep apnoea is under-recognised in women, and no gene test will ever find it |
What I see in clinic. The pattern I meet most often is a woman in her forties with a printed gene report, a shelf of methylated B vitamins she is not sure are doing anything, and no ferritin result from the last two years.
The report is usually accurate. It just answered a question she was not the one asking.
When we go back and get the ordinary bloods, more often than not there is something in them with a clearer story than the gene has.
An MTHFR result, or a wider panel
These are two different things and they answer two different questions, so it helps to know which one you are being offered.
A narrow MTHFR test reads two positions in one gene. You get one line back: which of 677C>T and 1298A>C you carry. That is a real result. Given how common these two variants are, it is also a result you could half guess before you paid for it. And it tells you nothing about your folate, your B12 or your homocysteine, all of which are blood tests, and all of which move.
A broader methylation panel reads a set of genes across the same pathway instead of two positions in one of them, so a variation in one place can be read next to what sits either side of it. It is still inherited sequence. It still cannot tell you what is in your blood today. As context for a conversation, though, it carries more than a single line does.
If you got here after seeing the overseas methylation test everyone has been posting about, I have written about that one separately.
The version we use in Australia is the genetic methylation test, and it comes with someone reading it next to your history and your bloods rather than emailing you a PDF. The honest order, if you want it: current bloods first, a broader panel second, a two-position gene test a long way below both.
What to do this week
None of this costs anything.
- Book a standard GP appointment and ask for the bloods in the table above by name. Take the list in on your phone.
- If you have had bloods in the last two years, ask for a copy and look for ferritin, B12, folate and TSH by name. “Normal” in a letter and “actually on the form” are two different things.
- Keep a two-week note. When the fog is worst, what you had eaten, how you slept, where you are in your cycle. It is unglamorous, and it is the most useful thing anyone brings me.
- Eat the folate as well as thinking about supplementing it. Leafy greens and legumes, and in Australia the wheat flour used for bread-making has folic acid added to it by law, so most people are getting more than they realise. In the last national biomedical survey, fewer than 1% of Australian women aged 16 to 44 had red cell folate in the at-risk range.
And before you buy a gene test, ask yourself:
- What would I do differently on Monday if it came back positive?
- Would I do anything differently if it came back negative?
- Has anyone looked at my iron, B12, folate and thyroid in the last two years?
- Am I buying a test, or am I buying an explanation?
There is no wrong answer to the last one. I have bought things for the same reason. It is just cheaper to notice it before you pay.
Not sure whether any of this is worth testing?
If you have a gene result and no idea what to do with it, or you are trying to work out whether to spend the money at all, book a free 15-minute call and we will talk it through. I will say so if the answer is your GP and a blood form, because most weeks it is.
Book a free 15-minute callGeneral information only. Nothing here replaces care from your GP.
Common questions
What are signs you may have MTHFR?
There are none that belong to it. People search MTHFR because of tiredness, brain fog, low mood, hormone symptoms or trouble with supplements, but those come from many things, and the two common variants are carried by 60 to 70 per cent of the population. A result tells you what you inherited, not what is producing your symptoms.
How do you know if you have MTHFR deficiency?
The two common variants are found by a gene test, and they are not a deficiency. Severe MTHFR deficiency is a separate, rare inherited condition that presents early and is not caused by the 677C>T or 1298A>C variants. If someone has told you that you are deficient on the basis of a common variant, that is worth clarifying with your GP.
Is MTHFR testing covered by Medicare?
There is no Medicare item for MTHFR testing on its own. The RACGP notes that the item usually used, 73308, is written for investigating proven venous thrombosis or pulmonary embolism, not for MTHFR. Ordered privately it is out of pocket, so it is worth asking what the result would change before you pay.
Is it worth getting tested for MTHFR?
The RACGP position is that GPs should not order it, because care does not change on the result. If your question is about folate, B12 or homocysteine, those are blood tests and they answer it directly. A gene panel can be useful context alongside bloods and history, but it is not the first thing I would spend money on.
Can I test myself for MTHFR?
Yes. Several Australian providers sell MTHFR or wider methylation gene panels direct to the public, usually a cheek swab or a finger prick posted to a lab. The sample is the easy part. The harder part is what to do with the report, so it is worth knowing who will read it with you before you order.
What vitamin is best for MTHFR?
No vitamin is for a gene. Folate and B12 are the nutrients in this pathway, and whether you need more of either is a question about your levels, your diet and your medications, not your genotype. That is a conversation to have with your GP or your practitioner alongside a blood test, not something a gene report can answer.
Sources
- RACGP, First Do No Harm patient resource: MTHFR gene testing, last revised November 2022.
- Long S, Goldblatt J. MTHFR genetic testing: controversy and clinical implications. Australian Family Physician 2016;45(4). Variant frequencies and the MBS item note come from here.
- Hickey SE, Curry CJ, Toriello HV. ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing. Genetics in Medicine 2013;15(2):153-6. PMID 23288205.
- Clarke R, et al. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality. Archives of Internal Medicine 2010;170(18):1622-31. PMID 20937919. The figure is drawn from the rate ratios reported here.
- Australian Bureau of Statistics, Australian Health Survey: Biomedical Results for Nutrients, 2011-12. Fewer than 1% of women aged 16 to 44 had red cell folate in the at-risk range.
- Food Standards Australia New Zealand, mandatory folic acid fortification.
- Centre for Genetics Education, MTHFR gene testing.
- NHMRC Nutrient Reference Values, folate.
Important: This article is general information written by a clinical nutritionist. It is not medical advice and does not replace care from your GP or another qualified health professional. Functional testing does not diagnose, treat, cure or prevent any condition, and results are best interpreted alongside your symptoms, history, medications and supplements.
Written and reviewed by Georgina Waugh
Clinical Nutritionist, BHSc Nutritional Medicine
Last updated: 13 July 2026
Sources reviewed: RACGP, the ACMG practice guideline, a meta-analysis of eight randomised trials, ABS biomedical survey data and FSANZ fortification standards.